Hypoxium has been acquired by Horizon Discovery, and will now be trading as Horizon Discovery Services, a wholly-owned subsidiary of Horizon Discovery.
Please view the Press Release or visit the Horizon Discovery website for more information.
Company
Overview
Based in Cambridge UK, Horizon Discovery Services provides comprehensive, high quality and affordable custom cell biology research services within the oncology therapeutic area. Our goal is to provide scientifically driven and industry focused pre-clinical solutions, to assist in the development of novel therapies for oncology. We understand the flexible and collaborative approach that is needed to make your programs successful. We collaborate:
- Early in drug development to provide critical proof-of-concept data
- During hit validation to develop assays and screen compounds
- Through lead optimization to validate mechanism of action of compounds
Horizon Discovery Services can support your projects from proof-of concept through to pre-clinical evaluation of new chemical entities.
Formed in October 2006, we have quickly established industry standard laboratories and recruited cell biologists with relevant oncology expertise. Since our formation we have attracted a wide range of clients and successfully delivered results that have significantly contributed to their discovery programs.
